NEWTOWN, Pa., July 21, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and ...
Stroke remains one of the leading causes of long-term disability worldwide, affecting millions each year. Among its most debilitating consequences is gait impairment, which affects over 80% of stroke ...
Phagenesis, a commercial-stage company with a first-of-its-kind neuromodulation system to treat patients experiencing difficulty swallowing post-stroke, welcomed the 2026 Guideline for the Early ...